How can we measure immune checkpoint inhibitor (ICI) response from core needle biopsies (CNB) ex vivo? 

Evaluating a live CNB presents two distinct challenges: 1) limited tissue and 2) intra-tumor heterogeneity. The Elephas Live™ Method addresses these challenges using a sequential treatment strategy rather than a traditional cross-well comparison. In the video below, Lindsey Vedder, PhD walks you through a poster explaining the sequential treatment strategy.